Harvey Sadow Net Worth & Insider Trades
Harvey Sadow - Director, Anika Therapeutics Inc
What is Harvey Sadow's Net Worth?
The current estimated net worth of Anika Therapeutics Inc's Director, Harvey Sadow, is estimated to be about $691.83K . Harvey Sadow owns about 10,000 units of Anika Therapeutics Inc common stock. In the last 3 years at Anika Therapeutics Inc, Harvey Sadow has sold an estimated value of $603.67K worth.
What is Harvey Sadow's Past Insider Trading?
Harvey Sadow's largest purchase order was 14,500 units , worth over $45.31K on October 25, 2005. Harvey Sadow's largest sale order was 13,300 units , worth over $182.98K on September 12, 2006. In total, Harvey Sadow has made about 9 transactions over 3 years of their time at Anika Therapeutics Inc. Harvey Sadow usually trades in September, with the busiest year in 2004 and 2005.
HARVEY SADOW
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Anika Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Cheryl R. Blanchard, Ph.D. | 2020 | $548,077 | $458,510 | $5,335,439 | $3,659,450 | $27,958 | $10,029,434 |
| Michael L. Levitz | 2020 | $173,077 | $73,601 | $799,971 | $799,993 | $11,318 | $1,857,960 |
| David Colleran | 2020 | $344,077 | $143,931 | $645,900 | $553,445 | $18,263 | $1,705,616 |
| Thomas Finnerty | 2020 | $353,505 | $143,169 | $626,367 | - | $20,746 | $1,143,787 |
| James Loerop | 2020 | $381,563 | $171,703 | $464,449 | - | $22,156 | $1,039,871 |
| Joseph G. Darling | 2020 | $80,752 | - | - | - | $208,001 | $288,753 |
| Sylvia Cheung | 2020 | $294,252 | - | $924,637 | - | $89,644 | $1,308,534 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm
What are Anika Therapeutics Inc's Past Insider Trades?
Anika Therapeutics Inc's most recent insider trade came on May 12, 2022 by David Colleran who bought 1,500 units worth $32.05K . In the last 18 years, insiders at Anika Therapeutics Inc have sold an estimated value of $66.56M and bought an estimated value of $5.82M worth of shares. Insider trading is most common in February, with the busiest year in 2006 and 2017. The most active traders at the company are Charles H Sherwood, CEO and Director, Steve Wheeler, Director, and Joseph L Bower, Director .
Anika Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||